Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
YL-17231
i
Other names:
YL-17231, TEB-17231, YL17231
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Shanghai YingLi Pharma
Drug class:
pan-KRAS inhibitor
Related drugs:
‹
BI-2493 (4)
BI 1701963 (1)
BI-2493 (4)
BI 1701963 (1)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12C
Solid Tumor
KRAS G12C
Solid Tumor
YL-17231
Sensitive: D – Preclinical
YL-17231
Sensitive
:
D
YL-17231
Sensitive: D – Preclinical
YL-17231
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.